Evidence map›Paper›PMID 38965172›Full record

ArticleMolecular neurobiology2025

Navβ2 Intracellular Fragments Contribute to Aβ1-42-Induced Cognitive Impairment and Synaptic Deficit Through Transcriptional Suppression of BDNF.

Min-Nan Lu, Dan Wang, Chen-Jun Ye, Guo-Ji Yan, Jing-Feng Song, Xin-Ying Shi, Shan-Shan Li, Li-Na Liu, Hui-Xiang Zhang, Xiao-Han Dong and 3 more

Abstract read
PubMed Publisher
In one paragraph

Article in Molecular neurobiology, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

13 authors.

Min-Nan Lu *Institute of Neuroscience, Kunming Medical University, Kunming, 650500, Yunnan, China.
Dan Wang *Institute of Neuroscience, Kunming Medical University, Kunming, 650500, Yunnan, China.
Chen-Jun YeInstitute of Neuroscience, Kunming Medical University, Kunming, 650500, Yunnan, China.
Guo-Ji YanInstitute of Neuroscience, Kunming Medical University, Kunming, 650500, Yunnan, China.
Jing-Feng SongSchool of Pharmaceutical Science and Yunnan Key Laboratory of Pharmacology for Natural Products, Kunming Medical University, Kunming, 650500, Yunnan, China.
Xin-Ying ShiInstitute of Neuroscience, Kunming Medical University, Kunming, 650500, Yunnan, China.
Shan-Shan LiExperimental Teaching Center, Basic Medical College, Kunming Medical University, Kunming, 650500, Yunnan, China.
Li-Na LiuInstitute of Neuroscience, Kunming Medical University, Kunming, 650500, Yunnan, China.
Hui-Xiang ZhangInstitute of Neuroscience, Kunming Medical University, Kunming, 650500, Yunnan, China.
Xiao-Han DongInstitute of Neuroscience, Kunming Medical University, Kunming, 650500, Yunnan, China.
Tao HuDepartment of Laboratory Medicine, The Third People's Hospital of Yunnan Province, Kunming, 650000, Yunnan, China.
Xu-Yang WangDepartment of Neurosurgery, Shanghai Sixth People's Hospital Affiliated to Shanghai Jiao Tong University School of Medicine, Shanghai, 200233, China.
Yan-Bin XiyangInstitute of Neuroscience, Kunming Medical University, Kunming, 650500, Yunnan, China. xiyangyanbin@kmmu.edu.cn.

Funding

National Natural Science Foundation of China, China 81960210Yunnan Province Science and Technology Department, China 202101AY070001-005Yunnan Province Science and Technology Department, China 202201AT070295
6 · The paper itself

Abstract

A pathological hallmark of Alzheimer's disease (AD) is the region-specific accumulation of the amyloid-beta protein (Aβ), which triggers aberrant neuronal excitability, synaptic impairment, and progressive cognitive decline. Previous works have demonstrated that Aβ pathology induced aberrant elevation in the levels and excessive enzymatic hydrolysis of voltage-gated sodium channel type 2 beta subunit (Navβ2) in the brain of AD models, accompanied by alteration in excitability of hippocampal neurons, synaptic deficits, and subsequently, cognitive dysfunction. However, the mechanism is unclear. In this research, by employing cell models treated with toxic Aβ1-42 and AD mice, the possible effects and potential mechanisms induced by Navβ2. The results reveal that Aβ1-42 induces remarkable increases in Navβ2 intracellular domain (Navβ2-ICD) and decreases in both BDNF exons and protein levels, as well as phosphorylated tropomyosin-related kinase B (pTrkB) expression in cells and mice, coupled with cognitive impairments, synaptic deficits, and aberrant neuronal excitability. Administration with exogenous Navβ2-ICD further enhances these effects induced by Aβ1-42, while interfering the generation of Navβ2-ICD and/or complementing BDNF neutralize the Navβ2-ICD-conducted effects. Luciferase reporter assay verifies that Navβ2-ICD regulates BDNF transcription and expression by targeting its promoter. Collectively, our findings partially elucidate that abnormal enzymatic hydrolysis of Navβ2 induced by Aβ1-42-associated AD pathology leads to intracellular Navβ2-ICD overload, which may responsible to abnormal neuronal excitability, synaptic deficit, and cognition dysfunction, through its transcriptional suppression on BDNF. Therefore, this work supplies novel evidences that Navβ2 plays crucial roles in the occurrence and progression of cognitive impairment of AD by transcriptional regulatory activity of its cleaved ICD.

Indexed as

Amyloid beta-PeptidesBrain-Derived Neurotrophic FactorCognitive DysfunctionPeptide FragmentsSynapsesAlzheimer DiseaseAnimalsHippocampusHumansIntracellular SpaceMaleMiceMice, Inbred C57BLNeuronsTranscription, GeneticVoltage-Gated Sodium Channel beta-2 SubunitAmyloid beta-Peptidesamyloid beta-protein (1-42)Brain-Derived Neurotrophic FactorPeptide FragmentsVoltage-Gated Sodium Channel beta-2 SubunitAlzheimer’s diseaseBrain-derived neurotrophic factorCognitive impairmentVoltage-gated sodium channel beta 2 (Navβ2) subunit

Identifiers

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.